quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:03:44·100d
INSIDERFiling
Lisata Therapeutics Inc. logo

Director Brown Gregory B was granted 30,456 shares, increasing direct ownership by 47% to 95,659 units (SEC Form 4)

LSTA· Lisata Therapeutics Inc.
Health Care
Original source

Companies

  • LSTA
    Lisata Therapeutics Inc.
    Health Care

Related

  • SEC8d
    SEC Form SC14D9C filed by Lisata Therapeutics Inc.
  • SEC8d
    SEC Form 8-K filed by Lisata Therapeutics Inc.
  • SEC21d
    Lisata Therapeutics Inc. filed SEC Form 8-K: Financial Statements and Exhibits
  • SEC21d
    SEC Form SC14D9C filed by Lisata Therapeutics Inc.
  • SEC42d
    SEC Form 10-K filed by Lisata Therapeutics Inc.
  • SEC45d
    SEC Form SC14D9C filed by Lisata Therapeutics Inc.
  • SEC45d
    Lisata Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure
  • PR48d
    Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022